Herida Magid, Sednaoui Patrice, Goulet Veronique
Infectious Diseases Department, Institut de Veille Sanitaire, Saint-Maurice, France.
Sex Transm Dis. 2004 Apr;31(4):209-14. doi: 10.1097/01.olq.0000118426.66742.9e.
The objectives of this study were to monitor epidemiologic trends in Neisseria gonorrhoeae (NG) infections and to assess antimicrobial resistance patterns of NG.
RENAGO, a voluntary-based laboratory surveillance system, including private and public laboratories, was set up in France in 1986. Every NG strain isolated by the participating laboratories was sent to the National Reference Center, Institut Alfred Fournier, Paris, where susceptibility to 6 antibiotics was tested. These laboratories reported monthly numbers of positive NG isolates and associated epidemiologic data. Because the number of laboratories varied every year, the average number of NG isolates per laboratory per year was computed to monitor annual trends in gonorrhea incidence.
The average number of NG isolated per laboratory per year decreased steadily from 10.6 in 1986 to 0.6 in 1997 but then yearly increased and reached 1.9 in 2000. Increasing gonorrhea was observed mostly in men and in the Paris area. The proportion of rectal strains increased significantly from 0.9% in 1986 to 9.2% in 2000. From 1998 to 2000, 5.3% of the isolates had reduced susceptibility or were resistant to ciprofloxacin, 7.3% were PPNG strains and 27.4% were resistant to tetracycline, 18.5% had a reduced susceptibility to thiamphenicol, and 1 strain was resistant to the latter. Neither strain was resistant to ceftriaxone or to spectinomycin.
From 1998 to 2000, gonorrhea markedly increased in France and seemed to affect mainly gay men in Paris, which suggests relapses to risky sexual behaviors and highlights the need for strengthening prevention. During the same period, NG ciprofloxacin resistance has sharply increased and should be carefully monitored because of the wide use of ciprofloxacin single-dose treatment.
本研究的目的是监测淋病奈瑟菌(NG)感染的流行病学趋势,并评估NG的抗菌药物耐药模式。
RENAGO是一个基于自愿的实验室监测系统,包括私立和公立实验室,于1986年在法国建立。参与实验室分离出的每株NG菌株都被送往巴黎的国家参考中心阿尔弗雷德·富尼耶研究所,在那里检测其对6种抗生素的敏感性。这些实验室每月报告阳性NG分离株的数量及相关的流行病学数据。由于每年参与的实验室数量不同,计算了每个实验室每年NG分离株的平均数,以监测淋病发病率的年度趋势。
每个实验室每年分离出的NG平均数从1986年的10.6稳步下降至1997年的0.6,但随后逐年上升,到2000年达到1.9。淋病增加主要见于男性和巴黎地区。直肠菌株的比例从1986年的0.9%显著增加至2000年的9.2%。1998年至2000年,5.3%的分离株对环丙沙星敏感性降低或耐药,7.3%为产青霉素酶淋球菌(PPNG)菌株,27.4%对四环素耐药,18.5%对甲砜霉素敏感性降低,1株对甲砜霉素耐药。没有菌株对头孢曲松或大观霉素耐药。
1998年至2000年,法国淋病显著增加,似乎主要影响巴黎的男同性恋者,这提示危险行为复发,凸显了加强预防的必要性。同一时期,NG对环丙沙星的耐药性急剧增加,鉴于环丙沙星单剂量治疗的广泛应用,应予以密切监测。